Thermo Fisher Scientific Inc. logo
Thermo Fisher Scientific Inc. (TMO)
Compare

Thermo Fisher Scientific Inc. (TMO) EV/Assets Ratio: 1.98x

Is Thermo Fisher Scientific Inc.’s EV/Assets ratio high or low?

Thermo Fisher Scientific Inc.'s EV/Assets ratio of 1.98x is 23% below its 5-year average of 2.57x, near the low end of its 5-year range (1.80x–3.93x).

The EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO) is 1.98x as of Tuesday, June 9, 2026. It is below its 12-month average by 8.13% (2.16x).

TMO EV/Assets Ratio Chart

TMO EV/Assets Ratio
1.98x+5.88% 1Y
Zoom

TMO Average EV/Assets Ratio Chart

TMO Current vs Average EV/Assets Ratio Chart

TMO EV/Assets Ratio Metrics

EV/ASSETS RATIO

1.98x

EV/ASSETS RATIO AVG TTM

2.16x

EV/ASSETS RATIO AVG 3Y

2.33x

EV/ASSETS RATIO AVG 5Y

2.57x

EV/ASSETS RATIO AVG 10Y

2.40x

EV/ASSETS RATIO AVG 15Y

2.04x

EV/ASSETS RATIO AVG 20Y

1.82x

CURRENT VS TTM AVG

-8.13%

CURRENT VS 3Y AVG

-15.11%

CURRENT VS 5Y AVG

-23.03%

CURRENT VS 10Y AVG

-17.41%

CURRENT VS 15Y AVG

-3.17%

CURRENT VS 20Y AVG

+8.97%

TMO Competitors' EV/Assets Ratio

NAMEMARKET CAPEV/ASSETS RATIOTTM3Y5Y
Thermo Fisher Scientific Inc. (TMO)1.98x2.16x2.33x2.57x
Amgen Inc. (AMGN)$185.96B2.52x2.46x2.26x2.38x
Abbott Laboratories (ABT)$158.94B1.69x2.51x2.67x2.75x
Gilead Sciences, Inc. (GILD)$155.82B3.05x3.05x2.43x2.15x
Intuitive Surgical, Inc. (ISRG)$151.09B7.53x8.89x9.09x8.50x
Pfizer Inc. (PFE)$146.48B1.01x1.00x1.03x1.28x
Danaher Corporation (DHR)$133.37B1.76x1.98x2.16x2.26x
CVS Health Corporation (CVS)$123.84B0.76x0.67x0.63x0.70x
Bristol-Myers Squibb Company (BMY)$115.34B1.74x1.54x1.56x1.64x
Vertex Pharmaceuticals Incorporated (VRTX)$113.14B4.18x4.45x4.69x4.46x

Thermo Fisher Scientific Inc. EV/Assets Ratio Formula & Definition

EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Thermo Fisher Scientific Inc. EV/Assets Ratio FAQ

What is the EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO)?
The EV/Assets ratio for TMO stock is 1.98x.
Is Thermo Fisher Scientific Inc.'s EV/Assets ratio high or low?
Thermo Fisher Scientific Inc.'s EV/Assets ratio of 1.98x is 23% below its 5-year average of 2.57x, near the low end of its 5-year range (1.80x–3.93x).
What is the TTM average EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO)?
The TTM average EV/Assets ratio for TMO stock is 2.16x.
What is the 3Y average EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO)?
The 3Y average EV/Assets ratio for TMO stock is 2.33x.
What is the 5Y average EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO)?
The 5Y average EV/Assets ratio for TMO stock is 2.57x.
What is the 10Y average EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO)?
The 10Y average EV/Assets ratio for TMO stock is 2.40x.
What is the 15Y average EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO)?
The 15Y average EV/Assets ratio for TMO stock is 2.04x.
What is the 20Y average EV/Assets ratio for Thermo Fisher Scientific Inc. (TMO)?
The 20Y average EV/Assets ratio for TMO stock is 1.82x.

Thermo Fisher Scientific Inc. EV/Assets Ratio History

DATEEV/ASSETS RATIO
2026-06-091.98x
2026-06-081.90x
2026-06-051.91x
2026-06-041.94x
2026-06-031.91x
2026-06-021.94x
2026-06-011.98x
2026-05-291.97x
2026-05-281.96x
2026-05-271.85x
2026-05-261.83x
2026-05-221.83x
2026-05-211.83x
2026-05-201.84x
2026-05-191.83x
2026-05-181.81x
2026-05-151.80x
2026-05-141.83x
2026-05-131.82x
2026-05-121.86x
2026-05-111.84x
2026-05-081.88x
2026-05-071.91x
2026-05-061.91x
2026-05-051.89x
2026-05-041.88x
2026-05-011.90x
2026-04-301.92x
2026-04-291.87x
2026-04-281.89x
2026-04-271.88x
2026-04-241.89x
2026-04-231.88x
2026-04-222.04x
2026-04-212.07x
2026-04-202.08x
2026-04-172.08x
2026-04-162.04x
2026-04-152.10x
2026-04-142.08x
2026-04-132.04x
2026-04-101.98x
2026-04-091.99x
2026-04-082.00x
2026-04-071.95x
2026-04-061.95x
2026-04-021.96x
2026-04-011.97x
2026-03-311.96x
2026-03-301.92x
2026-03-271.90x
2026-03-261.95x
2026-03-251.96x
2026-03-241.96x
2026-03-231.91x
2026-03-201.90x
2026-03-191.89x
2026-03-181.87x
2026-03-171.90x
2026-03-161.89x
2026-03-131.87x
2026-03-121.91x
2026-03-111.97x
2026-03-101.99x
2026-03-092.02x
2026-03-062.00x
2026-03-052.05x
2026-03-042.03x
2026-03-032.02x
2026-03-022.02x
2026-02-272.06x
2026-02-262.06x
2026-02-252.21x
2026-02-242.22x
2026-02-232.22x
2026-02-202.20x
2026-02-192.22x
2026-02-182.21x
2026-02-172.17x
2026-02-132.18x
2026-02-122.20x
2026-02-112.26x
2026-02-102.31x
2026-02-092.33x
2026-02-062.32x
2026-02-052.32x
2026-02-042.40x
2026-02-032.42x
2026-02-022.46x
2026-01-302.45x
2026-01-292.50x
2026-01-282.56x
2026-01-272.62x
2026-01-262.63x
2026-01-232.62x
2026-01-222.67x
2026-01-212.66x
2026-01-202.60x
2026-01-162.60x
2026-01-152.62x
2026-01-142.61x
2026-01-132.55x
2026-01-122.59x
2026-01-092.60x
2026-01-082.55x
2026-01-072.59x
2026-01-062.60x
2026-01-052.57x
2026-01-022.50x
2025-12-312.45x
2025-12-302.47x
2025-12-292.47x
2025-12-262.46x
2025-12-242.45x
2025-12-232.46x
2025-12-222.44x
2025-12-192.41x
2025-12-182.39x
2025-12-172.39x
2025-12-162.42x
2025-12-152.44x
2025-12-122.43x
2025-12-112.45x
2025-12-102.43x
2025-12-092.39x
2025-12-082.41x
2025-12-052.43x
2025-12-042.44x
2025-12-032.46x
2025-12-022.46x
2025-12-012.47x
2025-11-282.49x
2025-11-262.50x
2025-11-252.52x
2025-11-242.48x
2025-11-212.48x
2025-11-202.43x
2025-11-192.43x
2025-11-182.44x
2025-11-172.41x
2025-11-142.45x
2025-11-132.46x
2025-11-122.48x
2025-11-112.48x
2025-11-102.44x
2025-11-072.43x
2025-11-062.40x
2025-11-052.41x
2025-11-042.40x
2025-11-032.40x
2025-10-312.41x
2025-10-302.38x
2025-10-292.39x
2025-10-282.39x
2025-10-272.41x
2025-10-242.44x
2025-10-232.44x
2025-10-222.42x
2025-10-212.39x
2025-10-202.33x
2025-10-172.32x
2025-10-162.31x
2025-10-152.27x
2025-10-142.27x
2025-10-132.26x
2025-10-102.26x
2025-10-092.30x
2025-10-082.30x
2025-10-072.32x
2025-10-062.33x
2025-10-032.33x
2025-10-022.26x
2025-10-012.28x
2025-09-302.11x
2025-09-292.03x
2025-09-262.04x
2025-09-252.02x
2025-09-242.05x
2025-09-232.06x
2025-09-222.08x
2025-09-192.09x
2025-09-182.10x
2025-09-172.07x
2025-09-162.10x
2025-09-152.07x
2025-09-122.09x
2025-09-112.14x
2025-09-102.08x
2025-09-092.10x
2025-09-082.12x
2025-09-052.14x
2025-09-042.13x
2025-09-032.11x
2025-09-022.12x
2025-08-292.14x
2025-08-282.13x
2025-08-272.13x
2025-08-262.13x
2025-08-252.14x
2025-08-222.17x
2025-08-212.11x
2025-08-202.15x
2025-08-192.16x
2025-08-182.12x
2025-08-152.13x
2025-08-142.11x
2025-08-132.11x
2025-08-122.09x
2025-08-112.03x
2025-08-082.02x
2025-08-072.00x
2025-08-061.98x
2025-08-052.04x
2025-08-042.04x
2025-08-012.03x
2025-07-312.09x
2025-07-302.13x
2025-07-292.15x
2025-07-282.16x
2025-07-252.13x
2025-07-242.12x
2025-07-232.09x
2025-07-221.94x
2025-07-211.85x
2025-07-181.89x
2025-07-171.93x
2025-07-161.90x
2025-07-151.90x
2025-07-141.93x
2025-07-111.97x
2025-07-101.95x
2025-07-091.91x
2025-07-081.93x
2025-07-071.91x
2025-07-031.95x
2025-07-021.94x
2025-07-011.92x
2025-06-301.86x
2025-06-271.87x
2025-06-261.88x
2025-06-251.87x
2025-06-241.85x
2025-06-231.83x
2025-06-201.83x
2025-06-181.81x
2025-06-171.80x
2025-06-161.85x
2025-06-131.84x
2025-06-121.89x
2025-06-111.89x
2025-06-101.89x
2025-06-091.87x
2025-06-061.84x
2025-06-051.83x
2025-06-041.85x
2025-06-031.83x
2025-06-021.82x
2025-05-301.84x
2025-05-291.85x
2025-05-281.84x

Showing the most recent 260 of 5,031 data points. The chart above shows the full history.

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Waltham, MA
125,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Marc N. Casper